-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
Improving cancer clinical trial design and clinical practice: the case for tobacco use in cancer patients
Graham W Warren, Erica N Peters
Editorial: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
JAK2 inhibitors in the treatment of myeloproliferative neoplasms: rationale and clinical data
Raoul Tibes, Ruben Mesa
Review Article: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation